At the news
? NEUTRALIMPACT 3/10 8-K filed Mar 3, 2026 at 16:43 ET
Pliant Therapeutics extended the expiration date of its shareholder rights agreement from March 11, 2026 to March 11, 2027. The amendment is designed to prevent coercive takeover attempts by requiring potential acquirers to negotiate with the board, but was not made in response to any specific offer.
- Pliant Therapeutics extended the expiration of its shareholder rights agreement by one year, from March 11, 2026 to March 11, 2027
- The rights agreement allows the board to delay or prevent unsolicited takeover attempts
- The amendment was not made in response to any specific takeover offer
- The rights may still be redeemed, exchanged, or terminated earlier under existing terms
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access